Clinical trial
Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in…
NCT00429962 · University Hospital, Basel, Switzerland, Other · Completed
Key facts
| NCT number | NCT00429962 |
|---|---|
| Title | Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV |
| Official title | Randomized, Phase IIIb Study Comparing Safety, Tolerability and Efficacy Between Lucentis® Administered in Conjunction With PDT With Visudyne® and Lucentis® in Patients With Subfoveal CNV Secondary to Age-Related Macular Degeneration |
| Lead sponsor | University Hospital, Basel, Switzerland, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Choroidal Neovascularization, Age-Related Macular Degeneration |
| Intervention type | Drug |
| Interventions | intravitreal ranibizumab, intravitreal ranibizumab & photodynamic therapy |
| Enrollment | 40 |
| Start date | Jul 1, 2006 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Feb 1, 2007 |
| Last update posted | Apr 7, 2009 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: